关键信息
-
基因名
SD
- 应用
-
别名
SD；KIAA1835；SD；Ran GTPase-activating Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P46060
-
表达区间
2-587aa
-
氨基酸序列
ASEDIAKLA ETLAKTQVAG GQLSFKGKSL KLNTAEDAKD VIKEIEDFDS LEALRLEGNT VGVEAARVIA KALEKKSELK RCHWSDMFTG RLRTEIPPAL ISLGEGLITA GAQLVELDLS DNAFGPDGVQ GFEALLKSSA CFTLQELKLN NCGMGIGGGK ILAAALTECH RKSSAQGKPL ALKVFVAGRN RLENDGATAL AEAFRVIGTL EEVHMPQNGI NHPGITALAQ AFAVNPLLRV INLNDNTFTE KGAVAMAETL KTLRQVEVIN FGDCLVRSKG AVAIADAIRG GLPKLKELNL SFCEIKRDAA LAVAEAMADK AELEKLDLNG NTLGEEGCEQ LQEVLEGFNM AKVLASLSDD EDEEEEEEGE EEEEEAEEEE EEDEEEEEEE EEEEEEEPQQ RGQGEKSATP SRKILDPNTG EPAPVLSSPP PADVSTFLAF PSPEKLLRLG PKSSVLIAQQ TDTSDPEKVV SAFLKVSSVF KDEATVRMAV QDAVDALMQK AFNSSSFNSN TFLTRLLVHM GLLKSEDKVK AIANLYGPLM ALNHMVQQDY FPKALAPLLL AFVTKPNSAL ESCSFARHSL LQTLYKV
-
分子量
63.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
The research on SD (signal-disordered) recombinant proteins has gained significant attention in recent years due to their potential applications in various biotechnological and pharmaceutical fields. SD proteins are characterized by their unique structural properties that arise from the presence of intrinsically disordered regions, which allow them to interact with multiple binding partners and perform diverse biological functions. This flexibility makes them essential in processes such as signal transduction, cellular regulation, and protein-protein interactions. Advances in genomic sequencing and structural biology have enabled the identification and characterization of numerous SD proteins across various organisms, leading to a deeper understanding of their roles in cellular mechanisms and disease pathways. Additionally, the development of recombinant DNA technology has facilitated the production and study of SD proteins in vitro, opening avenues for engineering novel proteins with desired functionalities. Researchers are particularly interested in harnessing these proteins for therapeutic applications, such as targeted drug delivery, enzyme replacement therapies, and the design of biosensors. As the understanding of SD proteins continues to grow, they hold promise for innovative solutions in medicine and biotechnology, making their study a dynamic and rapidly evolving field.
